Benitec Biopharma (BNTC) Competitors $12.77 +0.19 (+1.51%) (As of 12/17/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends BNTC vs. RCKT, BCYC, AVDL, COLL, SEPN, BCAX, ZYME, GYRE, PSTX, and PAHCShould you be buying Benitec Biopharma stock or one of its competitors? The main competitors of Benitec Biopharma include Rocket Pharmaceuticals (RCKT), Bicycle Therapeutics (BCYC), Avadel Pharmaceuticals (AVDL), Collegium Pharmaceutical (COLL), Septerna (SEPN), Bicara Therapeutics (BCAX), Zymeworks (ZYME), Gyre Therapeutics (GYRE), Poseida Therapeutics (PSTX), and Phibro Animal Health (PAHC). These companies are all part of the "pharmaceutical products" industry. Benitec Biopharma vs. Rocket Pharmaceuticals Bicycle Therapeutics Avadel Pharmaceuticals Collegium Pharmaceutical Septerna Bicara Therapeutics Zymeworks Gyre Therapeutics Poseida Therapeutics Phibro Animal Health Rocket Pharmaceuticals (NASDAQ:RCKT) and Benitec Biopharma (NASDAQ:BNTC) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, community ranking, earnings, dividends, media sentiment, risk, valuation, institutional ownership and analyst recommendations. Which has higher earnings and valuation, RCKT or BNTC? Benitec Biopharma has higher revenue and earnings than Rocket Pharmaceuticals. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioRocket PharmaceuticalsN/AN/A-$245.60M-$2.75-4.33Benitec Biopharma$80K3,705.85-$21.75MN/AN/A Do insiders and institutionals hold more shares of RCKT or BNTC? 98.4% of Rocket Pharmaceuticals shares are held by institutional investors. Comparatively, 52.2% of Benitec Biopharma shares are held by institutional investors. 28.5% of Rocket Pharmaceuticals shares are held by insiders. Comparatively, 1.3% of Benitec Biopharma shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. Do analysts prefer RCKT or BNTC? Rocket Pharmaceuticals currently has a consensus target price of $51.00, indicating a potential upside of 327.85%. Benitec Biopharma has a consensus target price of $24.43, indicating a potential upside of 91.30%. Given Rocket Pharmaceuticals' higher probable upside, equities research analysts plainly believe Rocket Pharmaceuticals is more favorable than Benitec Biopharma.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Rocket Pharmaceuticals 0 Sell rating(s) 1 Hold rating(s) 10 Buy rating(s) 0 Strong Buy rating(s) 2.91Benitec Biopharma 0 Sell rating(s) 0 Hold rating(s) 7 Buy rating(s) 2 Strong Buy rating(s) 3.22 Does the media prefer RCKT or BNTC? In the previous week, Benitec Biopharma had 3 more articles in the media than Rocket Pharmaceuticals. MarketBeat recorded 12 mentions for Benitec Biopharma and 9 mentions for Rocket Pharmaceuticals. Rocket Pharmaceuticals' average media sentiment score of 0.91 beat Benitec Biopharma's score of 0.45 indicating that Rocket Pharmaceuticals is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Rocket Pharmaceuticals 4 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Positive Benitec Biopharma 1 Very Positive mention(s) 0 Positive mention(s) 7 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Is RCKT or BNTC more profitable? Benitec Biopharma's return on equity of -60.28% beat Rocket Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Rocket PharmaceuticalsN/A -62.62% -54.17% Benitec Biopharma N/A -60.28%-53.02% Which has more volatility and risk, RCKT or BNTC? Rocket Pharmaceuticals has a beta of 1.01, meaning that its stock price is 1% more volatile than the S&P 500. Comparatively, Benitec Biopharma has a beta of 0.88, meaning that its stock price is 12% less volatile than the S&P 500. Does the MarketBeat Community favor RCKT or BNTC? Rocket Pharmaceuticals received 195 more outperform votes than Benitec Biopharma when rated by MarketBeat users. Likewise, 73.12% of users gave Rocket Pharmaceuticals an outperform vote while only 65.32% of users gave Benitec Biopharma an outperform vote. CompanyUnderperformOutperformRocket PharmaceuticalsOutperform Votes38973.12% Underperform Votes14326.88% Benitec BiopharmaOutperform Votes19465.32% Underperform Votes10334.68% SummaryRocket Pharmaceuticals beats Benitec Biopharma on 8 of the 15 factors compared between the two stocks. Ad Porter & CompanyHiding in the Bible New documentary reveals the lost wealth-building secret hidden deep within ancient religious texts from almost every civilization… an investment one expert says is “so perfect that only God could have created it.” Watch it now to discover how this asset that you’ve likely never considered before can produce returns so safe, secure, and endless it is nothing short of miraculous.This is the untold, true story of God’s Investment. Get Benitec Biopharma News Delivered to You Automatically Sign up to receive the latest news and ratings for BNTC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BNTC vs. The Competition Export to ExcelMetricBenitec BiopharmaPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$296.47M$6.86B$5.17B$9.32BDividend YieldN/A3.06%4.78%4.06%P/E RatioN/A10.75127.7717.55Price / Sales3,705.85285.811,261.39139.05Price / CashN/A56.6541.0437.95Price / Book2.735.394.894.92Net Income-$21.75M$151.81M$119.40M$225.78M7 Day Performance8.77%-5.54%14.54%-1.47%1 Month Performance19.57%0.33%17.43%5.36%1 Year Performance278.93%16.04%35.31%22.71% Benitec Biopharma Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BNTCBenitec Biopharma3.6559 of 5 stars$12.77+1.5%$24.43+91.3%+278.9%$296.47M$80,000.000.0020Analyst ForecastShort Interest ↑RCKTRocket Pharmaceuticals4.8614 of 5 stars$11.94-0.7%$51.00+327.1%-57.9%$1.09BN/A-4.37240Analyst RevisionBCYCBicycle Therapeutics3.5662 of 5 stars$15.39+11.4%$36.00+133.9%-13.5%$1.06B$26.98M-4.56240Analyst ForecastInsider TradeHigh Trading VolumeAVDLAvadel Pharmaceuticals2.7809 of 5 stars$10.99+5.8%$24.43+122.3%-23.3%$1.06B$138.16M-13.15154Short Interest ↑Positive NewsCOLLCollegium Pharmaceutical3.9712 of 5 stars$30.68+2.0%$42.60+38.9%+4.3%$989.43M$599.25M12.97210News CoveragePositive NewsSEPNSepterna1.7246 of 5 stars$21.83-2.5%$43.67+100.0%N/A$969.25MN/A0.00N/ABCAXBicara TherapeuticsN/A$17.53+0.2%$43.00+145.3%N/A$953.91MN/A0.0032ZYMEZymeworks3.0464 of 5 stars$13.83+9.9%$18.83+36.2%+46.9%$952.61M$76.01M-9.25290Analyst UpgradePositive NewsGYREGyre Therapeutics0.3679 of 5 stars$10.14+5.2%N/A-54.6%$948.30M$105.03M0.0040News CoverageGap UpPSTXPoseida Therapeutics3.7029 of 5 stars$9.52+0.1%$9.50-0.2%+193.2%$930.77M$64.70M-15.10260PAHCPhibro Animal Health4.1953 of 5 stars$22.74+0.3%$19.00-16.4%+97.9%$921.04M$1.05B52.561,940Analyst ForecastNews Coverage Related Companies and Tools Related Companies RCKT Alternatives BCYC Alternatives AVDL Alternatives COLL Alternatives SEPN Alternatives BCAX Alternatives ZYME Alternatives GYRE Alternatives PSTX Alternatives PAHC Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:BNTC) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersTrump’s Secret Manhattan ProjectOn January 20, a whole new Manhattan Project is set to begin: Trump’s Manhattan Project. Folks, I just s...Banyan Hill Publishing | SponsoredHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredSeeing is believing… Today, I want to share all the details with you… and show you how to leverage this incredible wealth-building ...Porter & Company | SponsoredUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Benitec Biopharma Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Benitec Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BNTC Stock Alerts